| |
Luminal (n = 289)
|
HER2 (n = 75)
|
Basal-like (n = 62)
|
Negative (n = 30)
|
P-value
|
|---|
|
Patient age
| | | | | |
|---|
|
Median (years)
|
56.0
|
55.2
|
54.0
|
52.7
|
0.64
|
|
Tumour size
| | | | | |
|
Median
|
18.0
|
22.0
|
22.5
|
20.5
|
0.40
|
|
Tumour grade
| | | | |
< 0.001
|
|
1
|
71 (25%)
|
4 (5%)
|
2 (3%)
|
4 (13%)
| |
|
2
|
156 (55%)
|
16 (22%)
|
12 (20%)
|
12 (40%)
| |
|
3
|
58 (20%)
|
54 (73%)
|
47 (77%)
|
14 (47%)
| |
|
Nodal status
| | | | |
0.75
|
|
Negative
|
162 (56%)
|
40 (54%)
|
34 (55%)
|
17 (57%)
| |
|
Positive
|
125 (44%)
|
34 (46%)
|
28 (45%)
|
13 (43%)
| |
|
Treg
| | | | |
< 0.001
|
|
< 15
|
159 (62%)
|
28 (39%)
|
19 (25%)
|
23 (92%)
| |
|
≥15
|
99 (38%)
|
43 (61%)
|
36 (75%)
|
2 (8%)
| |
|
median
|
7.64
|
33.54
|
25.46
|
0.83
| |
|
CXCL12
| | | | |
0.050
|
|
Negative
|
36 (26%)
|
22 (47%)
|
11 (41%)
|
6 (35%)
| |
|
Positive
|
102 (74%)
|
25 (53%)
|
16 (59%)
|
11 (65%)
| |
- Treg, regulatory T cells.
